Mural Oncology plc (MURA) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 62.16M | 81.56M | 117.65M | 152.92M | 183.79M | 213.06M | 239.43M | 277.34M | 4.96M | 274.82M | 4.82M |
| Cash & Short-Term Investments | 58.87M | 77.09M | 107.68M | 144.38M | 175.5M | 204.7M | 231.67M | 270.85M | 0 | 273.34M | 0 |
| Cash Only | 58.87M | 77.09M | 106.68M | 115.46M | 111.02M | 121.59M | 107.26M | 270.85M | 0 | 273.34M | 0 |
| Short-Term Investments | 0 | 0 | 1M | 28.92M | 64.48M | 83.12M | 124.41M | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 55K | 51K | 1.39M | 1M | 1.9M | 5.55M | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 2.08M | 4.46M | 711K | 805K | 751K | 628K | 620K | 787K | 2.7M | 0 | 1.83M |
| Total Non-Current Assets | 3.6M | 6M | 14.43M | 16.48M | 19.48M | 21.87M | 24.08M | 24.41M | 25.24M | 26.16M | 28.93M |
| Property, Plant & Equipment | 3.6M | 6M | 12.46M | 14.5M | 17.48M | 19.84M | 22.03M | 24.15M | 25.06M | 24.5M | 28.93M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 1.97M | 1.98M | 2M | 2.03M | 2.05M | 258K | 181K | 1.66M | 0 |
| Total Assets | 65.76M | 87.56M | 132.08M | 169.39M | 203.27M | 234.93M | 263.5M | 301.75M | 30.2M | 300.98M | 33.75M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -67.65% | -62.73% | -49.88% | -43.86% | 573.05% | -21.95% | - | 794.06% | - | - | - |
| Total Current Liabilities | 10.53M | 28.42M | 23.15M | 26.2M | 24.91M | 24.63M | 21.25M | 29.02M | 26.41M | 5.81M | 41.56M |
| Accounts Payable | 0 | 3.14M | 1.88M | 2.06M | 2.24M | 3.11M | 1.57M | 5.97M | 3.5M | 0 | 2.97M |
| Days Payables Outstanding | - | 1.04K | - | - | - | 1.26K | - | - | 1.64K | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.01M | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 235K | 4.76M | 921K | 8.16M | 5.45M | 4.55M | 3.05M | 5.86M | 11.21M | 0 | 7.1M |
| Current Ratio | 5.90x | 2.87x | 5.08x | 5.84x | 7.38x | 8.65x | 11.27x | 9.56x | 0.19x | 47.33x | 0.12x |
| Quick Ratio | 5.90x | 2.87x | 5.08x | 5.84x | 7.38x | 8.65x | 11.27x | 9.56x | 0.19x | 47.33x | 0.12x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 42K | 354K | 1.04M | 2.7M | 4.22M | 5.73M | 7.33M | 8.91M | 10.69M | 10.65M | 13.85M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 42K | 166K | 804K | 2.46M | 4.1M | 5.73M | 7.33M | 8.91M | 10.47M | 10.65M | 13.54M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 188K | 235K | 235K | 115K | 0 | 0 | 0 | 219K | 0 | 304K |
| Total Liabilities | 10.57M | 28.77M | 24.19M | 28.89M | 29.13M | 30.36M | 28.58M | 37.93M | 37.09M | 16.46M | 55.41M |
| Total Debt | 3.55M | 5.17M | 6.78M | 8.02M | 9.55M | 11.08M | 13.49M | 15.01M | 16.48M | 16.46M | 19.39M |
| Net Debt | -55.32M | -71.92M | -99.9M | -107.44M | -101.47M | -110.51M | -93.78M | -255.84M | 16.48M | -256.88M | 19.39M |
| Debt / Equity | 0.06x | 0.09x | 0.06x | 0.06x | 0.05x | 0.05x | 0.06x | 0.06x | - | 0.06x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 55.19M | 58.78M | 107.89M | 140.5M | 174.14M | 204.57M | 234.93M | 263.82M | -6.89M | 284.52M | -21.66M |
| Equity Growth % | -68.31% | -71.27% | -54.08% | -46.74% | 2626.71% | -28.1% | - | 1318.22% | - | - | - |
| Book Value per Share | 3.19 | 3.40 | 6.28 | 8.23 | 10.23 | 12.09 | 13.99 | 15.81 | -0.41 | 17.05 | -1.30 |
| Total Shareholders' Equity | 55.19M | 58.78M | 107.89M | 140.5M | 174.14M | 204.57M | 234.93M | 263.82M | -6.89M | 284.52M | -21.66M |
| Common Stock | 174K | 173K | 173K | 171K | 170K | 169K | 169K | 167K | 0 | 167K | 0 |
| Retained Earnings | -244.2M | -240.49M | -192.51M | -159.37M | -125.1M | -93.34M | -61.77M | -30.86M | 0 | 0 | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 1K | 0 | 0 | 0 | 0 | 0 | -6.89M | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |